Bixiye
P59-16 Organization Determination Additions for Platinum Blue - Effective January 23, 2017
Taariikhda uu dhaqangalayo Barnaamijka: Des 08, 2016
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2901 - 2910 ee natiijooyinka 3563
Bixiye
P51-16 Addition of a Drug (Belviq XR) to the Weight Loss Agents Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo barnaamijka: Okt 28, 2016
Bixiye
P19R2-18 Update: New Remittance Code OA-45/N801 for Purchased/Referred Care (PRC) - Eligible Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2018
Bixiye
P26-17 New Drug-Related Prior Authorization (PA) Criteria: Urea Cycle Disorders
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2017
Bixiye
P54-16 Added Reimbursement Policies
Taariikhda uu dhaqangalayo Barnaamijka: Nov 14, 2016
Bixiye
P18-17 New Drug-Related Prior Authorization Requirements for Nusinersen (Spinraza)
Taariikhda uu dhaqangalayo Barnaamijka: May 02, 2017
Bixiye
P62-17 Addition of Drug to the Parathyroid Hormone Analog for Osteoporosis Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo Barnaamijka: Nov 06, 2017
Bixiye
P22-18 2018 Renewal Changes Summary For Suppliers Of Durable Medical Equipment (DME)
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2018
Bixiye
P79-17 Clarification to MHCP PA Requirements for Pelvic Floor Stimulator
Taariikhda uu dhaqangalayo Barnaamijka: Des 12, 2017
Bixiye
P83-17 Clarification to MHCP Prior Authorization Requirements for Nusinersen (Spinraza)
Taariikhda uu dhaqangalayo Barnaamijka: Des 13, 2017